Chlophedianol hydrochloride 2.5 MG/ML / pyrilamine maleate 2.5 MG/ML Oral Solution — RxCUI 1593749
RxNorm drug concept · Semantic clinical drug
RxCUI 1593749
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1593749
Official nameChlophedianol hydrochloride 2.5 MG/ML / pyrilamine maleate 2.5 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aschlophedianol hydrochloride 12.5 MG / pyrilamine maleate 12.5 MG per 5 ML Oral Solution; chlophedianol HCl 12.5 MG / pyrilamine maleate 12.5 MG in 5 mL Oral Solution
FDA products mapped1
Package NDCs mapped3
Reported Medicaid activity (SDUD)36 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Chlophedianol hydrochloride 2.5 MG/ML / pyrilami... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Chlophedianol hydrochloride 2.5 MG/ML / pyrilamine maleate 2.5 MG/ML Oral Solution
RxCUI 1593749 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 5
The active substance itself — no strength, form, or brand attached yet.
-
Chlophedianol
21254IN -
Pyrilamine
9009IN -
Chlophedianol / pyrilamine
1429359MIN -
Chlophedianol hydrochloride
1014329PIN -
Pyrilamine maleate
82091PIN
-
Chlophedianol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Ninjacof
1593751BN
-
Ninjacof
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Chlophedianol / pyrilamine Oral Solution
1429358SCDF -
Chlophedianol hydrochloride / pyrilamine maleate Oral Solution
2649267SCDFP -
Chlophedianol / pyrilamine Oral Liquid Product
1429356SCDG -
Chlophedianol / pyrilamine Oral Product
1429357SCDG -
Chlophedianol hydrochloride / pyrilamine maleate Oral Liquid Product
2662534SCDGP -
Chlophedianol hydrochloride / pyrilamine maleate Oral Product
2660913SCDGP -
Chlophedianol / pyrilamine Oral Solution [Ninjacof]
1593753SBDF -
Chlophedianol hydrochloride / pyrilamine maleate Oral Solution [Ninjacof]
2657739SBDFP - +5 more in this family
-
Chlophedianol / pyrilamine Oral Solution
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Chlophedianol hydrochloride 2.5 MG/ML
1014330SCDC -
Pyrilamine maleate 2.5 MG/ML
1192680SCDC -
Chlophedianol hydrochloride 2.5 MG/ML / pyrilamine maleate 2.5 MG/ML Oral Solution [Ninjacof]
1593756SBD -
Chlophedianol hydrochloride 2.5 MG/ML / pyrilamine maleate 2.5 MG/ML [Ninjacof]
1593752SBDC
-
Chlophedianol hydrochloride 2.5 MG/ML
Showing up to 8 concepts per family — 18 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Chlophedianol hydrochloride 2.5 MG/ML
SCDC · 1014330 -
Pyrilamine maleate 2.5 MG/ML
SCDC · 1192680 -
Chlophedianol / pyrilamine Oral Solution
SCDF · 1429358 -
Chlophedianol hydrochloride / pyrilamine maleate Oral Solution
SCDFP · 2649267 -
Chlophedianol / pyrilamine Oral Liquid Product
SCDG · 1429356 -
Chlophedianol / pyrilamine Oral Product
SCDG · 1429357 -
Chlophedianol hydrochloride / pyrilamine maleate Oral Liquid Product
SCDGP · 2662534 -
Chlophedianol hydrochloride / pyrilamine maleate Oral Product
SCDGP · 2660913
Brand-Name Concepts
-
Chlophedianol hydrochloride 2.5 MG/ML / pyrilamine maleate 2.5 MG/ML Oral Solution [Ninjacof]
SBD · 1593756 -
Chlophedianol hydrochloride 2.5 MG/ML / pyrilamine maleate 2.5 MG/ML [Ninjacof]
SBDC · 1593752 -
Chlophedianol / pyrilamine Oral Solution [Ninjacof]
SBDF · 1593753 -
Chlophedianol hydrochloride / pyrilamine maleate Oral Solution [Ninjacof]
SBDFP · 2657739 -
Ninjacof Oral Liquid Product
SBDG · 1593754 -
Ninjacof Oral Product
SBDG · 1593755 -
Ninjacof
BN · 1593751
📦 FDA Products & Package NDCs
1 product · 3 package NDCs
3 package NDCs map to RxCUI 1593749 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 23359-0032-04 | 120 mL in 1 BOTTLE (23359-032-04) | Ninjacof | Centurion Labs, LLC | 2017-09-19 |
| 23359-0032-10 | 10 mL in 1 BOTTLE (23359-032-10) | Ninjacof | Centurion Labs, LLC | 2017-09-18 |
| 23359-0032-16 | 473 mL in 1 BOTTLE (23359-032-16) | Ninjacof | Centurion Labs, LLC | 2014-10-15 |
Observed labelers:
Centurion Labs, LLC (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.0792
Range $0.0792–$0.0792
· middle 50% $0.0792–$0.0792
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.